Skip to content

Accelerating Elimination of Lymphatic Filariasis in Odisha

Accelerating Elimination of Lymphatic Filariasis in Odisha, an Endemic State of India: Adaptation and Evaluation of a Multicomponent Intervention Strategy for Enhancing MDA Coverage and Drug Compliance - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082193
Enrollment
800
Registered
2025-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Multi-component intervention: The multi-component intervention in this study consists of community-based and school-based strategies to enhance awareness and preventive measures for LF

Sponsors

ICMR-Regional Medical Research Centre, Bhubaneswar
Lead Sponsor
WHOTDR
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Eligible participants are adult (aged 18 years and above) residents who have resided in the study area (selected four wards) for the past year and plan to continue residing for at least one more year.

Exclusion criteria

Exclusion criteria: FLHW, MAS and SHG members, local leaders and volunteers and school teachers, who were part of the training, will be excluded. Pregnant women will also be excluded as MDA is not given to them.

Design outcomes

Primary

MeasureTime frame
A 20% relative increase in MDA drug compliance within 6 months as assessed through pre-and post-intervention survey aat baseline and after 6 month respectively in the general population of the identified wards of Cuttack. A 20% relative increase in knowledge regarding LF within 6 months as assessed through pre-and post-intervention survey at baseline and after 6 month respectively in the general population of the identified wards of Cuttack.Timepoint: pre-intervention survey at baseline in April and post-intervention survey after 6 months in September

Secondary

MeasureTime frame
Increase in dedicated sessions on MDA in existing community platforms; trained FLHWs and stakeholders equipped with the necessary knowledge to facilitate successful MDA campaignsTimepoint: 6 months

Countries

India

Contacts

Public ContactDr Tanveer Rehman

ICMR- Regional Medical Research Centre, Bhubaneswar

drtanveerrehman@gmail.com8336922482

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026